Tela Bio Stock Buy Hold or Sell Recommendation
TELA Stock | USD 2.94 0.07 2.33% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Tela Bio is 'Strong Sell'. Macroaxis provides Tela Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Tela Bio positions.
Check out Tela Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide. In addition, we conduct extensive research on individual companies such as Tela and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Tela |
Execute Tela Bio Buy or Sell Advice
The Tela recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Tela Bio. Macroaxis does not own or have any residual interests in Tela Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Tela Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Tela Bio Trading Alerts and Improvement Suggestions
Tela Bio had very high historical volatility over the last 90 days | |
Tela Bio has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 58.45 M. Net Loss for the year was (46.66 M) with profit before overhead, payroll, taxes, and interest of 27.85 M. | |
Tela Bio currently holds about 27.73 M in cash with (40.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.9. | |
Latest headline from gurufocus.com: TELA Bio to Participate in Piper Sandlers 36th Annual Healthcare Conference |
Tela Bio Returns Distribution Density
The distribution of Tela Bio's historical returns is an attempt to chart the uncertainty of Tela Bio's future price movements. The chart of the probability distribution of Tela Bio daily returns describes the distribution of returns around its average expected value. We use Tela Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Tela Bio returns is essential to provide solid investment advice for Tela Bio.
Mean Return | 0.12 | Value At Risk | -4.83 | Potential Upside | 6.43 | Standard Deviation | 3.39 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Tela Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Tela Stock Institutional Investors
Shares | Pentwater Capital Management Lp | 2024-09-30 | 500 K | Millennium Management Llc | 2024-06-30 | 404.6 K | Perkins Capital Management Inc | 2024-09-30 | 225.2 K | Geode Capital Management, Llc | 2024-09-30 | 174.5 K | Goldman Sachs Group Inc | 2024-06-30 | 153.7 K | Renaissance Technologies Corp | 2024-09-30 | 148.9 K | Landscape Capital Management,llc | 2024-09-30 | 143.2 K | Gsa Capital Partners Llp | 2024-09-30 | 112.2 K | State Street Corp | 2024-06-30 | 107.4 K | Essex Woodlands Health Ventures | 2024-09-30 | 4.1 M | Aigh Capital Management, Llc | 2024-09-30 | 2.5 M |
Tela Bio Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (1.8M) | (620K) | (5.2M) | (6.1M) | (2.7M) | (2.9M) | |
Investments | (12.0M) | 9.1M | (627K) | (1.9M) | (1.5M) | (1.5M) | |
Change In Cash | 28.0M | 29.1M | (30.5M) | (1.9M) | 5.0M | 5.2M | |
Free Cash Flow | (28.2M) | (24.6M) | (31.1M) | (42.6M) | (41.5M) | (43.5M) | |
Depreciation | 582K | 525K | 535K | 1.2M | 808K | 645.3K | |
Other Non Cash Items | 2.1M | 1.8M | 2.1M | 4.1M | 1.6M | 2.1M | |
Capital Expenditures | 2.7M | 167K | 627K | 1.9M | 611K | 1.2M | |
Net Income | (22.4M) | (28.8M) | (33.3M) | (44.3M) | (46.7M) | (49.0M) | |
End Period Cash Flow | 45.3M | 74.4M | 43.9M | 42.0M | 47.0M | 44.2M | |
Change To Netincome | 2.6M | 4.0M | 5.8M | 6.9M | 8.0M | 5.1M |
Tela Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Tela Bio or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Tela Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Tela stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 3.45 | |
Ir | Information ratio | -0.0024 |
Tela Bio Volatility Alert
Tela Bio currently demonstrates below-average downside deviation. It has Information Ratio of 0.0 and Jensen Alpha of 0.06. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Tela Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Tela Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Tela Bio Fundamentals Vs Peers
Comparing Tela Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Tela Bio's direct or indirect competition across all of the common fundamentals between Tela Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Tela Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Tela Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Tela Bio by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Tela Bio to competition |
Fundamentals | Tela Bio | Peer Average |
Return On Equity | -3.42 | -0.31 |
Return On Asset | -0.41 | -0.14 |
Profit Margin | (0.60) % | (1.27) % |
Operating Margin | (0.49) % | (5.51) % |
Current Valuation | 142.79 M | 16.62 B |
Shares Outstanding | 39.39 M | 571.82 M |
Shares Owned By Insiders | 4.49 % | 10.09 % |
Shares Owned By Institutions | 51.72 % | 39.21 % |
Number Of Shares Shorted | 478.72 K | 4.71 M |
Price To Book | 22.99 X | 9.51 X |
Price To Sales | 1.73 X | 11.42 X |
Revenue | 58.45 M | 9.43 B |
Gross Profit | 27.85 M | 27.38 B |
EBITDA | (40.63 M) | 3.9 B |
Net Income | (46.66 M) | 570.98 M |
Cash And Equivalents | 27.73 M | 2.7 B |
Cash Per Share | 1.90 X | 5.01 X |
Total Debt | 41.08 M | 5.32 B |
Debt To Equity | 3.33 % | 48.70 % |
Current Ratio | 3.83 X | 2.16 X |
Book Value Per Share | (0.25) X | 1.93 K |
Cash Flow From Operations | (40.86 M) | 971.22 M |
Short Ratio | 1.74 X | 4.00 X |
Earnings Per Share | (1.69) X | 3.12 X |
Target Price | 9.2 | |
Number Of Employees | 227 | 18.84 K |
Beta | 0.97 | -0.15 |
Market Capitalization | 118.56 M | 19.03 B |
Total Asset | 78.05 M | 29.47 B |
Retained Earnings | (320.89 M) | 9.33 B |
Working Capital | 54.76 M | 1.48 B |
Net Asset | 78.05 M |
Note: Acquisition by Blizard Jeffrey of 6375 shares of Tela Bio subject to Rule 16b-3 [view details]
Tela Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Tela . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 17855.23 | |||
Daily Balance Of Power | (0.29) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 3.01 | |||
Day Typical Price | 2.99 | |||
Price Action Indicator | (0.10) | |||
Period Momentum Indicator | (0.07) |
About Tela Bio Buy or Sell Advice
When is the right time to buy or sell Tela Bio? Buying financial instruments such as Tela Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Tela Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All Next | Launch |
Check out Tela Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.69) | Revenue Per Share 2.789 | Quarterly Revenue Growth 0.259 | Return On Assets (0.41) | Return On Equity (3.42) |
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.